HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenyin Shi Selected Research

Malignant Mesothelioma

7/2022The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenyin Shi Research Topics

Disease

40Neoplasms (Cancer)
07/2022 - 06/2002
15Glioblastoma (Glioblastoma Multiforme)
07/2022 - 03/2014
11Brain Neoplasms (Brain Tumor)
12/2020 - 12/2014
10Glioma (Gliomas)
02/2021 - 12/2012
9Mycosis Fungoides
01/2022 - 03/2015
8Neoplasm Metastasis (Metastasis)
09/2020 - 08/2012
6AIDS-Related Complex (ARC)
09/2020 - 05/2015
4Lung Neoplasms (Lung Cancer)
05/2013 - 07/2009
3Arthrogryposis renal dysfunction cholestasis syndrome
01/2019 - 01/2013
3Necrosis
01/2016 - 11/2005
3Carcinoma (Carcinomatosis)
06/2009 - 11/2005
3Colorectal Neoplasms (Colorectal Cancer)
07/2006 - 06/2002
2Cicatrix (Scar)
07/2022 - 03/2021
2Basal Cell Carcinoma (Rodent Ulcer)
07/2021 - 06/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 06/2009
2Breast Neoplasms (Breast Cancer)
10/2020 - 11/2018
2Fatigue
01/2020 - 10/2014
2Melanoma (Melanoma, Malignant)
01/2017 - 04/2015
2Neurilemmoma (Schwannoma)
02/2016 - 08/2012
1Hydrocephalus (Hydrocephaly)
07/2022
1Malignant Mesothelioma
07/2022
1Wounds and Injuries (Trauma)
07/2022
1Dermatitis
01/2022
1Carcinosarcoma
07/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
06/2021
1Ovarian Neoplasms (Ovarian Cancer)
02/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Pneumonia (Pneumonitis)
12/2020
1Edema (Dropsy)
12/2020
1Herpes Simplex
11/2020
1Lymphoma (Lymphomas)
04/2020
1Neurobehavioral Manifestations
01/2020
1Hyperthermia
01/2020
1Vulvovaginal Candidiasis
01/2020
1Multiple Hamartoma Syndrome (Cowden's Disease)
01/2020
1Inflammation (Inflammations)
01/2020
1Meningioma (Meningiomas)
01/2020
1Neurologic Manifestations (Neurological Manifestations)
01/2020
1Pain (Aches)
01/2020
1Headache (Headaches)
01/2019
1Astrocytoma (Pilocytic Astrocytoma)
12/2018

Drug/Important Bio-Agent (IBA)

5Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 12/2012
5Bevacizumab (Avastin)FDA Link
03/2019 - 07/2008
4vandetanib (ZD6474)IBA
06/2009 - 11/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 01/2004
2Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2020
2SteroidsIBA
12/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
11/2020 - 02/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2012 - 07/2006
2Tyrosine Kinase InhibitorsIBA
06/2009 - 07/2006
2N-acetylcochinol-O-phosphateIBA
11/2005 - 11/2004
2EndostatinsIBA
01/2003 - 06/2002
1MelatoninIBA
01/2022
1Acetates (Acetic Acid Esters)FDA Link
01/2022
1Mechlorethamine (Nitrogen Mustard)FDA Link
01/2022
1O-GlcNAc transferaseIBA
01/2022
1Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2022
1Nonsense Codon (Nonsense Mutation)IBA
06/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2021
1Ursolic AcidIBA
02/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2021
1Antisense OligonucleotidesIBA
01/2021
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2021
1IGV-001IBA
01/2021
1Amino AcidsFDA Link
11/2020
1ProdrugsIBA
11/2020
1Insulin-Like PeptidesIBA
11/2020
1AcidsIBA
11/2020
1Neurofilament ProteinsIBA
11/2020
1Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA
11/2020
1Mitogen-Activated Protein KinasesIBA
11/2020
1N-acetylaspartate (N-acetyl aspartate)IBA
11/2020
1Thymidine KinaseIBA
11/2020
1Choline (Choline Chloride)IBA
11/2020
1MMEIBA
09/2020
1Antimitotic AgentsIBA
07/2020
1Methotrexate (Mexate)FDA LinkGeneric
04/2020
1InterleukinsIBA
01/2020
1Memantine (Namenda)FDA Link
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1Interleukin-23 (Interleukin 23)IBA
01/2020
1SolutionsIBA
01/2019
1Aurora KinasesIBA
01/2019
1MLN 8237IBA
01/2019

Therapy/Procedure

42Radiotherapy
01/2022 - 01/2003
26Therapeutics
07/2022 - 06/2002
8Re-Irradiation
01/2021 - 09/2015
7Drug Therapy (Chemotherapy)
01/2021 - 11/2005
4Particle Accelerators
01/2021 - 01/2016
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
09/2020 - 05/2013
3Brachytherapy
03/2021 - 03/2015
3Salvage Therapy
02/2021 - 09/2015
2Aftercare (After-Treatment)
12/2020 - 02/2008
2Immunotherapy
11/2020 - 09/2006
2Intramuscular Injections
01/2003 - 06/2002
1Ventriculoperitoneal Shunt
07/2022
1Adjuvant Radiotherapy
07/2021
1Mastectomy (Mammectomy)
01/2020
1Catheters
01/2020
1Palliative Care (Palliative Therapy)
12/2019